文献速递心血管MRUS

轻症COVID-19康复患者的多模态心脏影像、心脏症状与临床结局

Multimodality Cardiac Imaging, Cardiac Symptoms, and Clinical Outcomes in Patients Who Recovered from Mild COVID-19.
PubMed 文献 · Radiology · 2023-01-01

前瞻性单中心研究纳入122例轻症COVID-19康复者与22例COVID-19阴性对照,在SARS-CoV-2检测后3-6个月行心脏MRI和超声心动图并评估症状。COVID+组3-6个月心脏症状报告率高于对照(48% vs 23%,P=0.04),但超声和心脏MRI异常率两组无差异;native T1每增加10 ms与3-6个月(OR 1.09,95%CI 1.00-1.19,P=0.046)和12-18个月(OR 1.14,95%CI 1.01-1.28,P=0.028)心脏症状几率升高相关;随访期间无主要不良心脏事件。

要点

  • 轻症COVID-19康复者3-6个月心脏症状报告率48%,高于阴性对照的23%(P=0.04)。
  • 超声心动图异常率20%与对照23%无差异(P=0.77),心脏MRI异常率44%与对照41%无差异(P=0.82)。
  • native T1每增加10 ms与3-6个月心脏症状相关(OR 1.09,95%CI 1.00-1.19)。

核心结论

  • 轻症COVID-19康复者3-6个月报告的心脏症状多于对照,但超声心动图和心脏MRI异常率两组无差异;native T1升高与3-6个月和12-18个月的心脏症状相关;随访期间无主要不良心脏事件。

研究设计与样本

  • 前瞻性单中心研究,纳入2020年8月至2022年1月接受SARS-CoV-2 PCR检测者,122例COVID-19康复者(平均年龄42岁±13[SD],73例女性)和22例COVID-19阴性对照(平均年龄46岁±16[SD],13例女性);在检测后3-6个月行心脏MRI、超声心动图和心脏症状评估,12-18个月再次评估症状和结局;统计采用Fisher精确检验和logistic回归。

关键影像表现/征象

  • COVID+组3-6个月超声心动图至少一项异常者20%(24/122),对照组23%(5/22),两组无差异(P=0.77)。
  • COVID+组3-6个月心脏MRI至少一项异常者44%(54/122),对照组41%(9/22),两组无差异(P=0.82)。
  • COVID+组3-6个月报告心脏症状者48%(58/122),多于对照组的23%(4/22)(P=0.04)。

诊断标准与关键数值

  • native T1每增加10 ms与3-6个月心脏症状几率升高相关(OR 1.09,95%CI 1.00-1.19;P=0.046)。
  • native T1每增加10 ms与12-18个月心脏症状几率升高相关(OR 1.14,95%CI 1.01-1.28;P=0.028)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Many patients have persistent cardiac symptoms after mild COVID-19. However, studies assessing the relationship between symptoms and cardiac imaging are limited. Purpose To assess the relationship between multi-modality cardiac imaging parameters, symptoms, and clinical outcomes in patients recovered from mild COVID-19 compared to COVID-19 negative controls. Materials and Methods Patients who underwent PCR testing for SARS-CoV-2 between August 2020 and January 2022 were invited to participate in this prospective, single-center study. Participants underwent cardiac MRI, echocardiography, and assessment of cardiac symptoms at 3-6 months after SARS-CoV-2 testing. Cardiac symptoms and outcomes were also evaluated at 12-18 months. Statistical analysis included Fisher's exact test and logistic regression. Results This study included 122 participants who recovered from COVID-19 ([COVID+] mean age, 42 years ± 13 [SD]; 73 females) and 22 COVID-19 negative controls (mean age, 46 years ± 16 [SD]; 13 females). At 3-6 months, 20% (24/122) and 44% (54/122) of COVID+ participants had at least one abnormality on echocardiography and cardiac MRI, respectively, which did not differ compared to controls (23% [5/22]; P = .77 and 41% [9/22]; P = .82, respectively). However, COVID+ participants more frequently reported cardiac symptoms at 3-6 months compared to controls (48% [58/122] vs. 23% [4/22]; P = .04). An increase in native T1 (10 ms) was associated with increased odds of cardiac symptoms at 3-6 months (OR, 1.09 [95% CI: 1.00, 1.19]; P = .046) and 12-18 months (OR, 1.14 [95% CI: 1.01, 1.28]; P = .028). No major adverse cardiac events occurred during follow-up. Conclusion Patients recovered from mild COVID-19 reported increased cardiac symptoms 3-6 months after diagnosis compared to controls, but the prevalence of abnormalities on echocardiography and cardiac MRI did not differ between groups. Elevated native T1 was associated with cardiac symptoms 3-6 months and 12-18 months after mild COVID-19.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Hanneman K, Houbois C, Kei T, et al. Multimodality Cardiac Imaging, Cardiac Symptoms, and Clinical Outcomes in Patients Who Recovered from Mild COVID-19. Radiology. 2023. PMID: 37432085. doi:10.1148/radiol.230767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。